Advocacy intelligence hub — real-time data for patient organizations
M.D. Anderson Cancer Center — PHASE1, PHASE2
Saglik Bilimleri Universitesi — NA
Kirsten Johnson — EARLY_PHASE1
M.D. Anderson Cancer Center — PHASE1, PHASE2
Federal University of São Paulo — PHASE4
FBD Biologics Limited — PHASE1
Shaw Cancer Center — PHASE2
M.D. Anderson Cancer Center — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Andrea B Apolo, M.D., MD
National Cancer Institute (NCI)
📍 BETHESDA, MD
Charalampos Floudas, M.D., M.D
National Cancer Institute (NCI)
📍 BETHESDA, MD
Helen E Heslop, MD, MD
Baylor College of Medicine
📍 HOUSTON, TX
Helen Heslop, MD, MD
Baylor College of Medicine
📍 HOUSTON, TX
Andrea Necchi, MD
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Patricia H Hardenbergh, MD, M.D
Vail Health Shaw Cancer Center
📍 VAIL, CO